Bill Status of HB 99   102nd General Assembly

Short Description:  PRESCRIPTION DRUG REPOSITORY

House Sponsors
Rep. Jonathan Carroll, Stephanie A. Kifowit and Dagmara Avelar

Last Action  View All Actions

DateChamber Action
  1/10/2023HouseSession Sine Die

Statutes Amended In Order of Appearance
New Act
225 ILCS 85/4from Ch. 111, par. 4124
225 ILCS 120/15from Ch. 111, par. 8301-15
320 ILCS 50/10
410 ILCS 620/16from Ch. 56 1/2, par. 516
720 ILCS 570/102from Ch. 56 1/2, par. 1102
740 ILCS 20/3from Ch. 70, par. 903

Synopsis As Introduced
Creates the Prescription Drug Repository Program Act. Requires the Department of Public Health to, by rule, establish a prescription drug repository program, under which a donor may donate a prescription drug or supplies needed to administer a prescription drug for use by an individual who meets eligibility criteria specified by the Department. Sets forth requirements that prescription drugs or supplies must meet in order to be accepted and dispensed under the program. Provides that uninsured and underinsured individuals shall be given priority over other eligible persons for drugs and supplies donated under the Act. Provides that no drugs or supplies donated under the prescription drug repository program may be resold. Provides that nothing in the Act requires that a pharmacy or pharmacist participate in the prescription drug repository program. Provides for civil and criminal immunity for drug and supply manufacturers and individuals in relation to the donation, acceptance, or dispensing of prescription drugs or supplies under the prescription drug repository program. Imposes conditions on any rulemaking authority. Contains other provisions. Amends the Pharmacy Practice Act, the Wholesale Drug Distribution Licensing Act, the Senior Pharmaceutical Assistance Act, the Illinois Food, Drug and Cosmetic Act, the Illinois Controlled Substances Act, and the Cannabis and Controlled Substances Tort Claims Act to provide that persons engaged in donating or accepting, or packaging, repackaging, or labeling, prescription drugs to the extent permitted or required under the Prescription Drug Repository Program Act are exempt from provisions of those other Acts that might prohibit or otherwise regulate such activity.

Actions 
DateChamber Action
  1/13/2021HouseFiled with the Clerk by Rep. Jonathan Carroll
  1/14/2021HouseFirst Reading
  1/14/2021HouseReferred to Rules Committee
  2/18/2021HouseAdded Co-Sponsor Rep. Stephanie A. Kifowit
  2/23/2021HouseAssigned to Human Services Committee
  3/22/2021HouseTo Special Issues (HS) Subcommittee
  3/27/2021HouseRule 19(a) / Re-referred to Rules Committee
  4/20/2021HouseAdded Co-Sponsor Rep. Dagmara Avelar
  1/10/2023HouseSession Sine Die

Back To Top